Skip to main content

Table 5 Antibiotic resistance profile of Gram-negative bacteria isolates

From: Antibiotic resistance in patients with clinical features of healthcare-associated infections in an urban tertiary hospital in Sierra Leone: a cross-sectional study

Antibiotics

Resistance rate (%)®

E. coli N = 43

K. pneumoniae N = 31

P. aeruginosa N = 8

A. baumanii N = 14

E. cloacae N = 9

B. cepacia N = 1

M. morgagni N = 2

Imipenem

0.0

0.0

0.0

8.0

13.0

100.0

0.0

Meropenem

0.0

0.0

0.0

10.0

13.0

10.0

0.0

Ampicillin

93.0

90.0

–

93.0

–

–

–

Ampicillin-sulbactam

67.0

67.0

–

36.0

–

–

–

Ciprofloxacin

70.0

82.0

50.0

36.0

33.0

100.0

100.0

Levofloxacin

70.0

37.0

50.0

40.0

11.0

0.0

100.0

Moxifloxacin

14.0

13.0

0.0

33.0

0.0

–

–

Amikacin

0.0

6.0

13.0

17.0

0.0

100.0

0.0

Gentamycin

63.0

68.0

50.0

56.0

67.0

100.0

100.0

Tobramycin

50.0

33.0

43.0

29.0

44.0

100.0

0.0

Aztreonam

70.0

69.0

–

–

50.0

–

–

Trimethoprim-sulphamethoxazole

82.0

84.0

–

93.0

100.0

–

100.0

Nitrofurantoin

23.0

13.3

–

84.0

11.0

–

100.0

Ceftriaxone

70.0

68.0

–

36.0

67.0

–

50.0

Cefuroxime

72.0

71.0

–

–

–

–

100.0

Cefuroxime Axetil

72.0

71.0

–

–

–

–

100.0

Cefotetan

9.0

10.0

–

69.0

8.0

–

0.0

Cefazolin

73.0

71.0

–

92.0

89.0

–

100.0

Ceftazidime

60.0

65.0

50.0

46.0

22.0

0.0

100.0

Cefepime

62.0

58.0

25.0

29.0

29.0

0.0

100.0

  1. ® Percentages = number of resistant antibiotics/total number of antibiotics tested
  2. (−) Indicate not tested